Skip to content
Adrienne Monson – Lifestyle
Author:
CeleCor Therapeutics, Inc.
FDA ACCEPTS NEW DRUG APPLICATION FOR CELECOR’S INVESTIGATIONAL HEART-ATTACK DRUG
September 30, 2026
CELECOR COMPLETES SUBMISSION OF FDA NEW DRUG APPLICATION FOR INVESTIGATIONAL HEART-ATTACK DRUG
June 24, 2026